characteristics.text: SAMN41292632
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2024-05-09T15:03:33.300Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-09-19T15:37:27.640Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS26622847
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS26622847
characteristics.characteristic: SRA accession
characteristics.text: DNA
characteristics.characteristic: analyte type
characteristics.text: NCI_TBCRC043_Phase2
characteristics.characteristic: biospecimen repository
characteristics.text: 01_137
characteristics.characteristic: biospecimen repository sample id
characteristics.text: BREAST
characteristics.characteristic: body site
characteristics.text: phs003617
characteristics.characteristic: gap_accession
characteristics.text: 5999809
characteristics.characteristic: gap_sample_id
characteristics.text: 4852306
characteristics.characteristic: gap_subject_id
characteristics.text: Not available
characteristics.characteristic: histological type
characteristics.text: Yes
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Clinical Trial
characteristics.characteristic: study design
characteristics.text: Addition of Atezolizumab to Carboplatin Significantly Improves Survival of Patients with Metastatic Triple-Negative Breast Cancer: TBCRC 043 Phase 2 Randomized Clinical Trial
characteristics.characteristic: study name
characteristics.text: 01_137
characteristics.characteristic: submitted sample id
characteristics.text: 29
characteristics.characteristic: submitted subject id
characteristics.text: NCI_TBCRC043_Phase2
characteristics.characteristic: submitter handle
characteristics.text: Tumor DNA sample from BREAST of a human female participant in the dbGaP study "Addition of Atezolizumab to Carboplatin Significantly Improves Survival of Patients with Metastatic Triple-Negative Breast Cancer: TBCRC 043 Phase 2 Randomized Clinical Trial"
characteristics.characteristic: title